Lotte to buy BMS biomedicine plant for $160 mln

SEOUL– South Korea’s Lotte Group decided Friday to buy U.S. drug firm Bristol Myers Squibb (BMS)’s pharmaceutical factory in Syracuse, New York, for $160 million.Lotte’s board of directors approved the deal, which also includes BMS’s contract manufact…